Whitepaper
4 Oct 2024

Nanoformed API: A Superior Alternative to Solid Dispersions

PDF 758 kB

Cutting-edge nanotechnology is now emerging, with strong clinical evidence, as an alternative to amorphous solid dispersion (ASD), able to not only address bioavailability challenges but also deliver higher drug loads in much more patientfriendly formats with fewer and smaller pills and easier regimens.

Content provided by our supplier

Nanoform Finland Oy

  • FI
  • 2019
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Other

Other Content from Nanoform Finland Oy (3)

  • Brochure Nanoform brochure

    NanoImprove the Performance of Your Formulations Small and Large Molecule Formulations Across the Product Life Cycle.NanoImprove Small Molecules
    NanoImprove Large Molecules
    NanoImprove the Performance of Your BioFormulations With NanoParticles by Design
    Nanoforming Success Accelerated by Proprietary AI Technology STARMAP® Drives Predictions of NanoImprovement Success
  • Whitepaper "(b)(2) or not to be, that is the question* Strategies for patient-centric differentiation through the USFDA 505(b)(2) pathway

    USFDA 505(b)(2) submissions can be advantageous because they can often lead to faster routes to approval when compared to traditional development pathways while creating new, differentiated products with commercial value. Jamie Unwin, Commercial Insight Officer at Nanoform, sat down with Timothy Pang, Executive Director, Pharma Consulting at Informa Pharma Custom Intelligence to discuss unique performance insights from the last three years for key molecules approved by this pathway, and to reflect on how patient-centric drug development has generated commercial value. Further, they discussed their view on the future direction of the industry with regards to the adoption of 505(b)(2) approaches, and the key technological advances that can empower these. Read on to find out more.
  • Brochure Sustainability ebook

    small is green Small empowers your sustainability goals